Evidence map›Paper›PMID 30536466›Full record

ReviewEnvironmental and molecular mutagenesis2019

Understanding the importance of low-molecular weight (ethylene oxide- and propylene oxide-induced) DNA adducts and mutations in risk assessment: Insights from 15 years of research and collaborative discussions.

L H Pottenger, G Boysen, K Brown, J Cadet, R P Fuchs, G E Johnson, J A Swenberg

Abstract readReview
In one paragraph

Review in Environmental and molecular mutagenesis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Developing Structure-Activity Relationships forComputational toxicology (Amsterdam, Netherlands) · 2021
    Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

L H PottengerOlin Corporation/Blue Cube Operations, LLC, retired, LHP TOX CONSULT, LLC, Midland, MI, USA.
G BoysenDepartment of Environmental and Occupational Health and The Winthrop P Rockefeller Cancer Institute University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.ORCID 0000-0001-8364-9881
K BrownLeicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom.
J CadetInstitut Nanosciences et Cryogénie, CEA-Grenoble, Grenoble, France.ORCID 0000-0003-2594-9485
R P FuchsCentre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, Marseille, 13009, France.
G E JohnsonSwansea University, Institute of Life Sciences, Swansea, United Kingdom.ORCID 0000-0001-5643-9942
J A SwenbergUniversity of North Carolina, Chapel Hill, North Carolina, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interpretation and significance of DNA adduct data, their causal relationship to mutations, and their role in risk assessment have been debated for many years. An extended effort to identify key questions and collect relevant data to address them was focused on the ubiquitous low MW N7-alkyl/hydroxyalkylguanine adducts. Several academic, governmental, and industrial laboratories collaborated to gather new data aimed at better understanding the role and potential impact of these adducts in quantifiable genotoxic events (gene mutations/micronucleus). This review summarizes and evaluates the status of dose-response data for DNA adducts and mutations from recent experimental work with standard mutagenic agents and ethylene oxide and propylene oxide, and the importance for risk assessment. This body of evidence demonstrates that small N7-alkyl/hydroxyalkylguanine adducts are not pro-mutagenic and, therefore, adduct formation alone is not adequate evidence to support a mutagenic mode of action. Quantitative methods for dose-response analysis and derivation of thresholds, benchmark dose (BMD), or other points-of-departure (POD) for genotoxic events are now available. Integration of such analyses of genetox data is necessary to properly assess any role for DNA adducts in risk assessment. Regulatory acceptance and application of these insights remain key challenges that only the regulatory community can address by applying the many learnings from recent research. The necessary tools, such as BMDs and PODs, and the example datasets, are now available and sufficiently mature for use by the regulatory community. Environ. Mol. Mutagen. 60: 100-121, 2019. © 2018 The Authors. Environmental and Molecular Mutagenesis published by Wiley Periodicals, Inc. on behalf of Environmental Mutagen Society.

Indexed as

DNA AdductsDNA DamageEpoxy CompoundsEthylene OxideHumansMolecular WeightMutagenesisMutagensMutationRisk AssessmentDNA AdductsEpoxy CompoundsEthylene OxideMutagenspropylene oxideDNA adductsdose-responsegenotoxic effectsmutationsN7-alkyl/hydroxyalkylguanine adducts

Identifiers

PMID30536466
PMCPMC6590209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.